About Aptahem
Business Strategy
Business Model
History
Team
Portfolio
RNA-therapeutics
Apta-1
Apta-2
Apta-3
Intellectual Property and Patent
Our Research
Scientific Collaborations
Örebro Consortium
Seattle Children’s Research Institute (SCRI)
University Health Network (UHN)
Publications
Production
Mechanism of Action
About Sepsis
Investor
Rights Issue Autumn 2024
Market Potential
Company Information
Share information
General Meetings
Largest Owners
Financial Reports
Annual Reports
Interim Reports
Financial Calendar
Events
Share issues
Analyzes
Media
News
Newsletter
Presentations
Sepsis Seminar 2021
Contact
About Aptahem
Business Strategy
Business Model
History
Team
Portfolio
RNA-therapeutics
Apta-1
Apta-2
Apta-3
Intellectual Property and Patent
Our Research
Scientific Collaborations
Publications
Production
Mechanism of Action
About Sepsis
Investor
Rights Issue Autumn 2024
Market Potential
Company Information
Share information
General Meetings
Largest Owners
Financial Reports
Financial Calendar
Events
Share issues
Analyzes
Media
News
Newsletter
Presentations
Sepsis Seminar 2021
Contact
Interim Reports
Annual Reports
Interim Reports
The documents are only available in Swedish
2024
Half-year Report 2024
Interim Report Q1 2024
2023
Year-end Report 2023
Interim Report Q3 2023
Interim Report Q2 2023
Interim Report Q1 2023
2022
Interim Report Q3 2022
Half-year Report 2022
Interim Report Q1 2022
2021
Year-end Report 2021
Interim Report Q3 2021
Half-year report 2021
Interim Report Q1 2021
2020
Year-end Report 2020
Interim Report Q3 2020
Half-year Report 2020
Interim Report Q1 2020
2019
Year-end Report 2019
Interim Report Q3 2019
Half-year Report 2019
Interim Report Q1 2019
2018
Year-end Report 2018
Interim Report Q3 2018
Half-year Report 2018
Interim Report Q1 2018
2017
Year-end Report 2017
Interim Report Q3 2017
Half-year Report 2017
Interim Report Q1 2017
2016
Year-end Report 2016
Interim Report Q3 2016
Half-year Report 2016
Interim Report Q1 2016
2015
Year-end Report 2015
Interim Report Q3 2015
Half-year Report 2015
Interim Report Q1 2015
